Inhibition of ubiquitin-specific protease 13-mediated degradation of Raf1 kinase by Spautin-1 has opposing effects in naïve and primed pluripotent stem cells-Reference-Cited by-同舟云学术

Inhibition of ubiquitin-specific protease 13-mediated degradation of Raf1 kinase by Spautin-1 has opposing effects in naïve and primed pluripotent stem cells

Published:2021-11 Issue:5 Volume:297 Page:101332
ISSN:0021-9258
Container-title:Journal of Biological Chemistry
language:en
Short-container-title:Journal of Biological Chemistry

Author:

Wang Xin,Wang Xiaoxiao,Zhang Xinbao,Zhang Yan,Zhu Zhenhua,Li Yuting,Zhang Meng,Ji Junxiang,Yu Yang,Ye Shou-Dong^ORCID

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry

Reference42 articles.

1. Establishment in culture of pluripotential cells from mouse embryos;Evans;Nature,1981

2. Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells;Martin;Proc. Natl. Acad. Sci. U. S. A.,1981

3. Inhibition of pluripotential embryonic stem cell differentiation by purified polypeptides;Smith;Nature,1988

4. BMP induction of Id proteins suppresses differentiation and sustains embryonic stem cell self-renewal in collaboration with STAT3;Ying;Cell,2003

5. The ground state of embryonic stem cell self-renewal;Ying;Nature,2008

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The USP10/13 inhibitor, spautin-1, attenuates the progression of glioblastoma by independently regulating RAF-ERK mediated glycolysis and SKP2.;Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease;2024-10

2. Dynamic Roles of Signaling Pathways in Maintaining Pluripotency of Mouse and Human Embryonic Stem Cells;Cellular Reprogramming;2024-04-01

3. Targeting autophagy drug discovery: Targets, indications and development trends;European Journal of Medicinal Chemistry;2024-03

4. Unraveling time-inhibition mechanisms in mammalian cell-free protein synthesis;2024-01-25

5. Targeting CRAF kinase in anti-cancer therapy: progress and opportunities;Molecular Cancer;2023-12-18